LEDIPASVIR & SOFOSBUVIR:
HEPCINAT-LP contains the Drug / Molecules Ledipasvir & Sofosbuvir.
USAGE & DESCRIPTION :
HEPCINAT-LP has used for the treatment of chronic hepatitis C virus (HCV).
INTERNATIONAL BRAND NAME
TABLETS (IN PLASTIC BOTTLE)
NATCO PHARMA LIMITED. (INDIA) UNDER LICENSE FROM GILEAD SCIENCE IRELAND UC
CLINICAL APPLICATIONS :
Hepcinate LP is a fixed-dose combination of ledipasvir and sofosbuvir which are direct acting antiviral agents against the hepatitis C virus (HCV). Ledipasvir is an inhibitor of the protein, which is required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridineanalog triphosphate which can be incorporated into HCV RNA and acts as a chain terminator .
Store at a temperature not exceeding 30°C.